Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

NCT06933407 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-04-18

No results posted yet for this study

Summary

Strain elastography (SE) will be utilized as a non-invasive imaging technique to evaluate tissue elasticity and biomechanical properties in women with stress urinary incontinence (SUI) and in continent controls. The primary aim is to determine whether SE can detect differences in paraurethral tissue stiffness between these groups. Given the established role of tissue elasticity in the pathophysiology of SUI, SE will be investigated as a potential diagnostic tool in urogynecological evaluations.

This prospective cohort study will be conducted at a tertiary referral center. All participants will undergo introital two-dimensional (2D) ultrasound in the midsagittal plane at rest. SE will be performed in three predefined suburethral regions of interest (ROIs):

* internal urethral orifice (IUO) level
* midurethra (MU) level
* external urethral orifice (EUO) level

The adipose layer (AL) between the external urethral meatus and the pubic symphysis will serve as the reference tissue, representing the softest anatomical structure in the region.

Descriptive and comparative statistical analyses will be conducted to assess differences in paraurethral tissue stiffness between the study groups.

It is hypothesized that SE will be able to detect differences in paraurethral tissue elasticity, with SUI being associated with increased tissue compliance. The study also aims to determine whether SE can reliably distinguish between varying degrees of tissue stiffness in women with SUI and continent controls.

Pathophysiological focus:

The study will explore key mechanisms underlying SUI, including:

* Weakened bladder neck support
* Impaired urethral stabilization due to increased tissue elasticity and collagen degradation
* While conventional 2D ultrasound provides anatomical information, it does not directly evaluate tissue biomechanics. In contrast, SE enables real-time visualization of tissue elasticity, offering a promising adjunct to traditional urogynecological assessment methods.

Standardization and Protocol

The study will follow a standardized protocol to ensure reproducibility and high-quality data. Key methodological elements include:

* Minimal probe compression during introital ultrasound to avoid artifacts
* Bladder emptying prior to examination to eliminate confounding effects
* Carefully standardized ROI placement across all patients
* Controlled image acquisition conditions to reduce variability

Future Directions

* Future research based on this study will aim to:
* Optimize SE protocols and refine ROI placement strategies
* Establish clinical cutoff values for differentiating tissue stiffness in SUI vs. continent women
* Assess the long-term effects of pelvic floor muscle training (PFMT) and vaginal estrogen therapy on paraurethral biomechanics
* Facilitate the integration of SE into routine urogynecological practice to support early diagnosis and personalized treatment strategies for SUI

Conditions

  • Urinary Incontinence
  • Urinary Incontinence, Stress
  • Urinary Incontinence (UI)
  • Urinary Bladder, Overactive
  • Incontinence, Overactive Bladder, Stress Urinary Incontinence
  • Stress Urinary Incontinence (SUI)

Interventions

DIAGNOSTIC_TEST

Strain Elastography

Strain elastography (SE) is a parametric imaging modality that assesses tissue deformation in response to externally applied pressure, providing qualitative and semi-quantitative information on tissue elasticity and mechanical properties. Unlike conventional 2D ultrasound, SE enables the objective evaluation of paraurethral tissue stiffness, which may play a role in the pathophysiology of stress urinary incontinence (SUI). SE will be performed on three predefined paraurethral regions to assess pelvic floor elasticity and biomechanical characteristics. A standardized protocol will be implemented to ensure high reproducibility, with controlled probe compression and precisely defined regions of interest. SE may improve the diagnostic accuracy and therapeutic decision-making for SUI by identifying differences in tissue compliance among affected women.

Sponsors & Collaborators

  • Capio Specialized Center for Gynecology, Solna, 182 88 Stockholm, Sweden

    collaborator UNKNOWN
  • Szeged University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-16
Primary Completion
2025-03-30
Completion
2030-01-01

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06933407 on ClinicalTrials.gov